Success Metrics

Clinical Success Rate
90.0%

Based on 9 completed trials

Completion Rate
90%(9/10)
Active Trials
1(9%)
Results Posted
22%(2 trials)
Terminated
1(9%)

Phase Distribution

Ph not_applicable
3
27%
Ph early_phase_1
1
9%
Ph phase_2
5
45%
Ph phase_4
1
9%

Phase Distribution

1

Early Stage

5

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Early Phase 1First-in-human
1(10.0%)
Phase 2Efficacy & side effects
5(50.0%)
Phase 4Post-market surveillance
1(10.0%)
N/ANon-phased studies
3(30.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.0%

9 of 10 finished

Non-Completion Rate

10.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(9)
Terminated(1)

Detailed Status

Completed9
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
90.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (10.0%)
Phase 25 (50.0%)
Phase 41 (10.0%)
N/A3 (30.0%)

Trials by Status

terminated19%
completed982%
recruiting19%

Recent Activity

1 active trials
Showing 5 of 11
recruitingearly_phase_1

Early Neurovascular Adaptations in Aging Women

NCT06520982
completedphase_2

Dose-response Study of Sodium Nitroprusside in Children Requiring Controlled Hypotension in the Operating Room

NCT00135668
completedphase_2

Ketamine and Nitroprusside for Depression

NCT03102736
completed

Vascular Function and Uterine Fibroids

NCT02123069
completednot_applicable

Remifentanil and Nitroprusside for Controlled Hypotension

NCT02001298
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT06520982Early Phase 1

Early Neurovascular Adaptations in Aging Women

Recruiting
NCT00135668Phase 2

Dose-response Study of Sodium Nitroprusside in Children Requiring Controlled Hypotension in the Operating Room

Completed
NCT03102736Phase 2

Ketamine and Nitroprusside for Depression

Completed
NCT02123069

Vascular Function and Uterine Fibroids

Completed
NCT02001298Not Applicable

Remifentanil and Nitroprusside for Controlled Hypotension

Completed
NCT01125943Not Applicable

Bevacizumab and Endothelium Dependent Vasodilation

Completed
NCT00535808Phase 2

Effect of Strategy for Blood Pressure Control on Cerebral Oxygen Balance During Aortic Coarctation Repair: A Randomized Study

Completed
NCT00590070Phase 2

THE REOPEN-AMI STUDY - Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction

Completed
NCT00621816Phase 2

Sodium Nitroprusside for Blood Pressure Reduction in the ICU (SNP2)

Completed
NCT00226096Not Applicable

Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage

Completed
NCT00128791Phase 4

Nitroprusside for Prevention of no-Reflow in Primary Angioplasty

Terminated

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11